Cited 0 times in

Pembrolizumab plus chemotherapy for advanced gastric cancer – Authors' reply

Authors
 Sun Young Rha  ;  Sonal Bordia 
Citation
 LANCET ONCOLOGY, Vol.25(2) : e52, 2024-02 
Journal Title
LANCET ONCOLOGY
ISSN
 1470-2045 
Issue Date
2024-02
MeSH
Antibodies, Monoclonal, Humanized / adverse effects ; Antineoplastic Combined Chemotherapy Protocols / adverse effects ; Carcinoma, Non-Small-Cell Lung* / drug therapy ; Humans ; Lung Neoplasms* / drug therapy ; Stomach Neoplasms* / drug therapy
Full Text
https://www.sciencedirect.com/science/article/pii/S1470204524000226
DOI
10.1016/S1470-2045(24)00022-6
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Rha, Sun Young(라선영) ORCID logo https://orcid.org/0000-0002-2512-4531
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/201876
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links